<DOC>
	<DOC>NCT00440323</DOC>
	<brief_summary>Subjects will be screened within 28 days. Each treatment session will consist of 2 PSG nights, study drug administration and noise model is conducted on second night.</brief_summary>
	<brief_title>Disturbed Sleep Model Study.</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Body weight =50 kg and BMI within the range 18.529.9 kg/m2 inclusive Healthy as judged by responsible physician. No clinically significant abnormality identified on the medical or laboratory evaluation and 12lead ECG; The subject shows a normal sleep pattern on the basis of the evaluation of both PSG screening nights. Normal sleep will be defined as follows: LPS (Latency to persistence Sleep) &lt;30min., SE (Sleep Efficiency) &gt;85%, apnea/ hypopnea index &lt; 10, periodic leg movements (PLM) with arousal index &lt; 10. The apnea/hypopnea index is defined as "the number of apneas and hyponeas divided by the total sleep time (TST) expressed in hours". PLMI is defined as "the number of periodic leg movements associated with arousals or awakening divided by the total sleep time (TST) expressed in hour". A positive result for the prestudy urine drug/ alcohol breath screen. Abuse of alcohol. Subject complains of sleep disturbances and /or is receiving treatment for sleep disorders.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Noise induced Situational insomnia,</keyword>
	<keyword>healthy volunteers</keyword>
	<keyword>SB-649868,</keyword>
	<keyword>Zolpidem,</keyword>
</DOC>